REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Bayer S.A. (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing | Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Bayer S.A. Profile Updated: November 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Bayer Ecuador started in 1930, introducing several of its products in this country through J.H.Krüger y Bruckmann & Cía commercial companies. Currently the company is part of the conglomerate Bayer Andean Region and is exclusively dedicated to the import and marketing of German Bayer Holding. The business segments managed are care and animal health, nutrition and crop protection, and innovative materials

Headquarters
Luxemburgo N34-359, Cosmopolitan Parc Bldg. , Floor 6
Quito; Pichincha;

Contact Details: Purchase the Bayer S.A. report to view the information.

Website: http://www.bayerandina.com

Basic Information
Total Employees:
Purchase the Bayer S.A. report to view the information.
Outstanding Shares:
Purchase the Bayer S.A. report to view the information.
Registered Capital:
Purchase the Bayer S.A. report to view the information.
Incorporation Date:
May 22, 1967
Key Executives
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
100%
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Bayer S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-17.98%▼
Total operating revenue
-15.96%▼
Operating profit (EBIT)
44.58%▲
EBITDA
33.94%▲
Net Profit (Loss) for the Period
39.95%▲
Total assets
3.89%▲
Total equity
16.5%▲
Operating Profit Margin (ROS)
3.48%▲
Net Profit Margin
1.79%▲
Return on Equity (ROE)
1.12%▲
Debt to Equity Ratio
7.11%▲
Quick Ratio
0.05%▲
Cash Ratio
-0.12%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo